Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis

Summary

The purpose of this study is to assess the ease of use of the lebrikizumab pen. Participants will use a practice pad to simulate administration of a dose. Participants will complete the modified Subcutaneous Administration Assessment Questionnaire (mSQAAQ) following the simulated injection. This study involves one study visit.

Timeline

Start

2024-06-04

Primary completion

2024-06-10

Completion

2024-06-10

Drugs

Indications